VarCov Co’s ArriVent BioPharma AVBP Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$229K Sell
7,557
-594
-7% -$18.2K 0.11% 287
2026
Q2
$283K Buy
+8,151
New +$241K 0.11% 276

Other funds holding AVBP

VarCov Co's AVBP Position: Q3 2026 in Review

VarCov Co reduced its ArriVent BioPharma (AVBP) stake by 7.3% in Q3 2026, selling an estimated $18.2K and leaving 7,557 shares worth $229K. The position accounts for 0.11% of the portfolio, ranked #287.

VarCov Co first reported a position in AVBP in Q2 2026 and has held it in 2 quarters since. The position peaked at $283K in Q2 2026. 153 funds tracked by Wall St. Rank hold AVBP as of Q3 2026.

  • VarCov Co held 7,557 shares of ArriVent BioPharma worth $229K as of Q3 2026.
  • VarCov Co sold 594 ArriVent BioPharma shares in Q3 2026, an estimated $18.2K.
  • ArriVent BioPharma made up 0.11% of VarCov Co's portfolio in Q3 2026, its #287 holding.
  • VarCov Co first reported a position in ArriVent BioPharma in Q2 2026 and has held it in 2 quarters since.
  • VarCov Co's ArriVent BioPharma position peaked at $283K in Q2 2026.
  • 153 funds tracked by Wall St. Rank held ArriVent BioPharma as of Q3 2026.

Based on VarCov Co's 13F filing for Q3 2026, filed 16 Nov 2026.